XIX International AIDS Conference in Washington D.C. Interview with Takayuki Ota from The Scripps Research Institute in La Hoia, San Diego. He is part of the Creative and Novel Ideas in HIV Research Grants Program (CNIHR), a IAS and NIH collaboration.

XVII International AIDS Conference in Mexico City. American HIV/AIDS pioneer Dr Anthony Fauci from the National Institute of Allergy and Infectious Diseases (NIAID) talks about the disappointments of the latest HIV vaccine trials, and the leadership of Peter Piot.

XVII International AIDS Conference in Mexico City. American HIV/AIDS pioneer Dr Anthony Fauci from the National Institute of Allergy and Infectious Diseases (NIAID) talks about the disappointments of the latest HIV vaccine trials, and the leadership of Peter Piot.

XVII International AIDS Conference in Mexico City. Interview with Seth Berkley from the International AIDS Vaccine Initiative (IAVI). He talks about the recent media coverage of the failed HIV vaccine study and emphasizes on the positive outcomes of the research process.

XVII International AIDS Conference in Mexico City. Dr Daria Hazuda from MSD, who has been involved in antiretroviral drug development during the past 20 years, holds a presentation. She is also interviewed about leadership and the progress of ARV and vaccine development.

Interview with George Louis, Professor and Director at the division of Vaccine and Research at the Initiative of Human Virology (IHV) in Baltimore. He talks about the current HIV vaccine trials and reflects on the future.

Joep Lange discusses his views on antiretroviral drugs, both in the developing and the developed world, future improvements of HIV drugs and treatment, and a possible vaccine.

Robin Weiss, a British Molecular Biologist and Professor of Viral Oncology at University College London, talks about the scientific contribution of small countries like Sweden, interdisciplinary collaborations in HIV research and HIV vaccines.

Geoffrey Schild, Virologist and Director of the National Institute for Biological Standards and Control (NIBSC), talks about the Swedish contributions to AIDS research and collaboration with funding agencies such as Nutek, and reflects on HIV vaccines.

Dr George Galasso is working on HIV vaccines at NIAID. Here he talks about the scientific challenges of HIV/AIDS and the chances of developing a vaccine. He believes that one of the main focuses in HIV/AIDS research still is to find treatment for opportunistic infections.